STONEPINE CAPITAL MANAGEMENT, LLC aTyr Pharma, Inc. Transaction History

STONEPINE CAPITAL MANAGEMENT, LLC portfolio value:

$1.80M
portfolio value

STONEPINE CAPITAL MANAGEMENT, LLC quarter portfolio value change:

+6.01%
quarter

aTyr Pharma, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -0.10% -600 shares 101K $3 600.98K
Q2 2022 share 0.00% 0 shares -1.51M $2.83 601.58K
Q1 2022 share Increase +14.47% 76.04K shares -708K $5.35 601.58K
Q4 2021 share Increase +28.01% 114.99K shares 198K $7.5 525.53K
Q3 2021 share Increase 0.00% 410.53K shares 3.72M $9.08 410.53K